Drug Discovery And Development
Breaking News
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development
Siren Biotechnology, Catalent Partner for Manufacturing of AAV Gene Therapies
Catalent to support the development and manufacturing of Siren Biotechnology’s AAV immuno-gene therapies for cancer.05.17.24
-
Breaking News | Clinical Trials
Nuvalent’s NVL-655 Granted Breakthrough Therapy Designation by FDA
Will advance NVL-655 in recognition of the continued need for innovation for patients with ALK-positive NSCLC who have exhausted available therapies.05.17.24
-
Breaking News | cGMP Manufacture | Chemistry | Industry News | Information Technology
Veranova, Phorum.AI Partner on Generative AI Chemistry Optimization
Aims to enable development of optimized manufacturing processes in a fraction of the time versus historical methods.05.16.24
-
Biologics, Proteins, Vaccines | Breaking News | Trials & Filings
BMS’s CAR T Cell Therapy Breyanzi Approved for Follicular Lymphoma
Overall response rate was 95.7%, as defined as the percentage of patients achieving a partial or complete response.05.16.24
-
Breaking News | Collaborations & Alliances | Drug Discovery
Sartorius Expands AI Alliance with NVIDIA
Will combine Sartorius’ knowledge of life sciences and bioprocessing with NVIDIA’s AI-powered computing platforms and software.05.16.24
-
Bio News | Breaking News | Drug Development | Drug Discovery | Promotions & Moves
Regulus Therapeutics Names New Chief Medical Officer
Dr. Rekha Garg is a physician executive with over 20 years of experience in leadership roles in the biopharma industry.05.16.24
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
U.S. Biosecure Act Advances with Revised Timeline
WuXi Biologics added to list of biotech companies of concern, now provides U.S. companies until 2032 to find new service providers.05.15.24
-
Bio News | Breaking News | Collaborations & Alliances | Drug Development
FogPharma, ARTBIO Partner to Develop Helicon-Enabled ARTs (HEARTs)
Aim to transform outcomes for patients with multiple types of cancer.05.14.24
-
Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
Centogene and Evotec Discover New Potential Treatment for Gaucher Disease
Companies amend existing drug discovery partnership for Evotec to lead continued development.05.14.24
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News
Takeda, AC Immune Ink Exclusive Agreement for Alzheimer’s Immunotherapy
Worldwide option and license agreement includes AC Immune’s active immunotherapies targeting toxic forms of amyloid beta, including ACI-24.060.05.14.24
-
Breaking News | Collaborations & Alliances | Drug Discovery
NEOsphere, Kymera Therapeutics Collaborate on Novel Molecular Glue Target Discovery
Aim to create opportunities to target previously undruggable disease-causing proteins.05.14.24
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances
Aldevron, Acuitas Partner to Expand Capabilities in mRNA LNP Encapsulation
Collaboration increases Aldevron’s services and capabilities as an mRNA sequence-to-vial custom manufacturer.05.14.24
-
Information Technology | Regulatory Affairs
The Future of Pharmacovigilance is Proactive
Data and AI can unlock the path to proactivity.Bruce Palsulich, Vice President of Safety, Oracle Life Sciences 05.13.24
-
Analytical Services | Chemistry | Laboratory Testing | R&D
A New Approach to Particle Morphology
The particle size of the API and excipients affects more than just the stability and appearance of the product.Emil W. Ciurczak, Contributing Writer 05.13.24
-
Biologics, Proteins, Vaccines
CEO Spotlight: Gaston Salinas
The chief executive of Botanical Solution Inc. (BSI) speaks about the development of QS-21 adjuvant for vaccines from Quillaja saponaria trees grown in BSI labsTim Wright, Editor, Contract Pharma 05.13.24
-
Formulation Development | Process Development | Scale-up/Technology Transfer
Three Key Considerations of Complex Liquid Formulations
In this white paper, we delve into three key factors that affect your product across its lifecycle.05.13.24
-
Biologics, Proteins, Vaccines | Drug Development
The Transformative Potential of Gene Therapy
Gene therapy is having its moment. Can the clinical research ecosystem seize it?James Riddle, Senior Vice President, Global Review Operations, Advarra 05.13.24
-
Biologics, Proteins, Vaccines | Drug Development
CDMOs: The Cornerstone of Biopharmaceutical Innovation
CDMOs provide specialized support, knowledge, and infrastructure to accelerate drug development and get new drugs to the market sooner.Leonardo Magneschi, Head of Molecular Biology, Ingenza 05.13.24
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Promotions & Moves
ERS Genomics Appoints John E. Milad CEO
John brings more than 25 years of experience as an executive leader, venture capitalist, and investment banker focused on the life sciences.05.13.24
-
Breaking News | Collaborations & Alliances | Drug Development
Fulcrum Enters Collaboration & License Agreement with Sanofi
Following positive data from the Phase 3 trial, Fulcrum and Sanofi plan to submit marketing applications for losmapimod.05.13.24
